HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyun Woo Lee Selected Research

Neutropenia

1/2018Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
11/2014Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hyun Woo Lee Research Topics

Disease

23Neoplasms (Cancer)
12/2022 - 01/2009
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 09/2009
8Stomach Neoplasms (Stomach Cancer)
03/2021 - 01/2011
5Lung Neoplasms (Lung Cancer)
10/2022 - 07/2015
4Neoplasm Metastasis (Metastasis)
03/2022 - 11/2014
4Adenocarcinoma
11/2021 - 08/2017
4Sepsis (Septicemia)
11/2021 - 03/2010
4Pneumonia (Pneumonitis)
07/2021 - 11/2019
4COVID-19
07/2021 - 08/2020
4Pathologic Constriction (Stenosis)
03/2021 - 01/2018
4Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2017
4Alzheimer Disease (Alzheimer's Disease)
04/2017 - 10/2016
4Parkinson Disease (Parkinson's Disease)
04/2017 - 10/2016
3Infections
12/2021 - 02/2012
3Pancreatic Neoplasms (Pancreatic Cancer)
11/2021 - 02/2012
3Leukemia
11/2021 - 01/2011
3Hypoxia (Hypoxemia)
07/2021 - 01/2019
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2021 - 01/2008
3Disease Progression
08/2020 - 01/2011
3Hepatocellular Carcinoma (Hepatoma)
02/2020 - 11/2014
2Tuberculosis (Tuberculoses)
10/2022 - 12/2021
2Lung Diseases (Lung Disease)
10/2022 - 05/2019
2AIDS-Related Complex (ARC)
01/2022 - 01/2013
2Latent Tuberculosis
12/2021 - 05/2017
2Fever (Fevers)
11/2021 - 08/2020
2Ascites
03/2021 - 01/2018
2Obstructive Lung Diseases (Obstructive Lung Disease)
12/2020 - 01/2018
2Squamous Cell Carcinoma of Head and Neck
07/2020 - 01/2019
2Hemorrhage
02/2020 - 10/2012
2Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2019 - 02/2012
2Neutropenia
01/2018 - 11/2014
2Anhedonia
12/2017 - 01/2017
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2016 - 11/2014
2Acute Promyelocytic Leukemia
10/2015 - 03/2013
2Necrosis
05/2015 - 04/2012
2Febrile Neutropenia
11/2014 - 02/2012
2Obesity
02/2010 - 01/2009
1Bronchiectasis
10/2022
1Rheumatoid Arthritis
04/2022
1Joint Diseases (Joint Disease)
04/2022
1Contracture
04/2022
1Prosthesis Failure
04/2022
1Bone Resorption
03/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2022

Drug/Important Bio-Agent (IBA)

6PlatinumIBA
01/2021 - 09/2009
6Proteins (Proteins, Gene)FDA Link
11/2018 - 01/2006
5Biomarkers (Surrogate Marker)IBA
12/2022 - 07/2020
4Adrenal Cortex Hormones (Corticosteroids)IBA
10/2022 - 01/2018
4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2010
4GemcitabineFDA Link
11/2021 - 02/2012
4Messenger RNA (mRNA)IBA
07/2020 - 01/2015
4Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 01/2011
4Monoamine Oxidase (MAO)IBA
04/2017 - 10/2016
3Immune Checkpoint InhibitorsIBA
12/2022 - 01/2019
3ErbB Receptors (EGF Receptor)IBA
03/2022 - 01/2018
3Dexamethasone (Maxidex)FDA LinkGeneric
07/2021 - 12/2015
3Pharmaceutical PreparationsIBA
01/2021 - 01/2016
3Cholinergic Agents (Cholinergics)IBA
01/2019 - 01/2017
3SteroidsIBA
08/2018 - 12/2015
3Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 01/2011
3Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
04/2017 - 10/2016
2B7-H1 AntigenIBA
12/2022 - 01/2019
2antineoplaston A10 (A 10)IBA
10/2022 - 01/2019
2Tyrosine Kinase InhibitorsIBA
03/2022 - 01/2018
2folfirinoxIBA
11/2021 - 01/2018
2MetalsIBA
03/2021 - 07/2019
2Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 01/2018
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 01/2021
2Angiotensin Receptor AntagonistsIBA
01/2021 - 01/2021
2Muscarinic AntagonistsIBA
01/2021 - 11/2019
2Bronchodilator Agents (Bronchodilators)IBA
12/2020 - 01/2017
2Anti-Bacterial Agents (Antibiotics)IBA
08/2020 - 11/2014
2RNA (Ribonucleic Acid)IBA
01/2019 - 01/2019
2AlbuminsIBA
01/2018 - 11/2014
2Leucovorin (Folinic Acid)FDA Link
01/2018 - 01/2011
2Vincristine (Oncovin)FDA LinkGeneric
02/2016 - 11/2014
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2016 - 11/2014
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2016 - 11/2014
2Rituximab (Mabthera)FDA Link
02/2016 - 11/2014
2Thymidylate SynthaseIBA
01/2011 - 03/2010
2PPAR gammaIBA
02/2010 - 01/2009
1Particulate MatterIBA
10/2022
1CobaltIBA
03/2022
1ChromiumIBA
03/2022

Therapy/Procedure

23Therapeutics
12/2022 - 01/2011
21Drug Therapy (Chemotherapy)
10/2022 - 01/2008
5Adjuvant Chemotherapy
10/2022 - 02/2012
5Chemoradiotherapy
01/2022 - 03/2010
4Knee Replacement Arthroplasty (Total Knee Replacement)
04/2022 - 01/2020
3Cannula
07/2021 - 08/2019
3Stents
03/2021 - 07/2019
3Radiotherapy
03/2016 - 01/2008
2Mechanical Ventilators (Ventilator)
07/2021 - 01/2021
2Immunotherapy
07/2020 - 01/2020
2Combination Drug Therapy (Combination Chemotherapy)
03/2020 - 02/2012
2Self Expandable Metallic Stents
09/2019 - 07/2019
2Surgical Instruments (Clip)
01/2019 - 01/2018
2Salvage Therapy
01/2018 - 02/2015
2Hepatectomy
11/2014 - 11/2014
1Postoperative Care
04/2022